Name badge reading Annemarie SLUIJMERS from Lupus Europe at the European Reference Networks SKIN eventLupus Europe is proud to announce a significant milestone in the representation of people with skin lupus. Annemarie Sluijmers, Vice Chair and Secretary of Lupus Europe has taken an important step by becoming an ePAG (European Patient Advocacy Group) Patient Advocate of ERN Skin.Annemarie became an ePAG in July 2023. Her recent attendance at the ERN Skin Board Meeting in Paris on November 6, 2023, marks an important advancement for the lupus community.

 

ERN Skin, a dedicated network addressing complex skin disorders, had its board meeting to discuss the future direction of the structure of the network and its thematic groups, and as such the patient advocacy within ERN Skin. For the first time, the voice of people with skin lupus was thoroughly represented at ERN Skin. This representation is a vital step forward in ensuring that the specific challenges and needs of those affected by skin lupus and lupus with skin manifestations are heard and recognised.

 

AIBD/TOXITEN: A New Focus for Skin Lupus

 

During the meeting, a structural evolution of thematic groups was proposed. The groups have now been streamlined into four main categories:

 

Genodermatoses-1

Genodermatoses-2

AIBD/TOXITEN

ALLOCATE

 

Skin lupus will fall under the AIBD/TOXITEN group. The AIBD/TOXITEN group is a subset focusing on auto-immune and toxic epidermal diseases. This classification underscores the significance of lupus as an autoimmune condition with dermatological manifestations, ensuring that it receives the appropriate focus and resources.

Building a Strong Community in ERN Skin

 

As a newcomer to ERN Skin, Annemarie is swiftly becoming acquainted with the network’s intricacies, its organisational structure, and its ambitious work. A key priority is identifying a lupus dermatologist. A lupus dermatologist will represent together with Annemarie the lupus community in this new thematic AIBD/TOXITEN group.

 

The collaboration and support within the ERN Skin community have been exceptional. Fellow ePAGs are providing Annemarie with invaluable support as she navigates this new role.

 

For more updates, stay tuned to our blog and upcoming newsletters. Go here to find out more about work on Lupus and the Skin.

 

 

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

Today is rare disease day!

🚨 There are over 300 million people who live with a #raredisease in #europe.

🌎 Today, we join our fellow patient organisations that work towards a better life for people with rare diseases and their families.

🔴 Some facts about #rarediseases:

1️⃣ There are more than 6000 identified rare diseases.

2️⃣ Rare diseases currently affect 5% of the worldwide population.
The true impact of rare diseases is much wider, however, with those affected in Europe in the millions, as the disease affects not only the patient but also our loved ones.

3️⃣ 72% of genetic diseases are genetic, although #lupus is not one of them.
👉 Lupus is not a genetic disease. Although it is very much related to genes, there are other factors that play a role in its manifestation.

4️⃣ 👶Neonatal #lupus is a rare congenital disorder that some infants of mothers with lupus and anti-Ro/SSA and/or anti-La/SSB antibodies develop.
The most serious complication of neonatal lupus is a heart condition known as congenital heart block.

5️⃣ Having an early diagnosis is key to having access to the right treatment. This has an impact on physical and mental health and, therefore, on the quality of life.

Along with organisations like Rare Disease Day and EURORDIS-Rare Diseases Europe, we will carry on working towards an early diagnosis, access to treatment and equality for #raredisease patients 🙌.

Thank you for your support on this #rarediseaseday!

#ShareYourColours
... See MoreSee Less

Image attachment
Image attachment
Image attachment
Image attachment
Image attachment

#lupus is a #raredisease that affects nearly 500,000 people in Europe. Furthermore, there are over 300 million people who live with a #raredisease in #europe.

Today, along with Rare Disease Day, patient organisations around the world advocate for equity for people living with a rare disease

#ShareYourColours and help us spread the word by liking and sharing. Remember that you can also download the material of the official campaign on the website

f.mtr.cool/iyctvzvvtj
... See MoreSee Less

#Lupus is a #RareDis

Today is #RareDiseaseDay!

And we have joined Rare Disease Day campaign.

Everyone deserves equal opportunities, access to healthcare ➕ early diagnosis, which is key to setting a treatment plan &, hence, achieving a good quality of life.
#ShareYourColours

www.youtube.com/watch?v=7J1oTfoIOGw
... See MoreSee Less

Today is #RareDiseas

😃 Throwback to the HMA/EMA Multi-Stakeholder Workshop on Artificial Intelligence.

Watching Alain Cornet show the world what #LupusGPT really is still gives us goosebumps! 🙌

For those who still don't know this artificial intelligence tool:

💡 LupusGPT is built by patients and doctors.
🗣️ It speaks virtually any language.
💸 It’s free and anonymous- you don’t need to create an account.
📚 It is trained exclusively on a curated repository of validated documents.
🚫 It does not invent answers.

If something is not in the repository, LupusGPT will clearly say so. It will not guess. It will not generate false information.

🥹 Seeing LupusGPT presented at such a high-level regulatory forum confirmed something important:
Patient-led innovation can meaningfully contribute to the future of AI in medicine when it is built responsibly.

🔗 Try it here! lupusgpt.org/

🧠 Are medical terms confusing? Prefer shorter explanations in simple language?
Try #EasyLupus! The easy-read version of LupusGPT: easy.lupusgpt.org/
... See MoreSee Less

LUPUS EUROPE Uniting people with Lupus throughout Europe
Send